• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的代谢重编程和表观遗传修饰:从影响和机制到治疗潜力。

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.

机构信息

Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.

University of South China, Hengyang, 421001, Hunan, China.

出版信息

Exp Mol Med. 2023 Jul;55(7):1357-1370. doi: 10.1038/s12276-023-01020-1. Epub 2023 Jul 3.

DOI:10.1038/s12276-023-01020-1
PMID:37394582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10394076/
Abstract

Metabolic reprogramming and epigenetic modifications are hallmarks of cancer cells. In cancer cells, metabolic pathway activity varies during tumorigenesis and cancer progression, indicating regulated metabolic plasticity. Metabolic changes are often closely related to epigenetic changes, such as alterations in the expression or activity of epigenetically modified enzymes, which may exert a direct or an indirect influence on cellular metabolism. Therefore, exploring the mechanisms underlying epigenetic modifications regulating the reprogramming of tumor cell metabolism is important for further understanding tumor pathogenesis. Here, we mainly focus on the latest studies on epigenetic modifications related to cancer cell metabolism regulations, including changes in glucose, lipid and amino acid metabolism in the cancer context, and then emphasize the mechanisms related to tumor cell epigenetic modifications. Specifically, we discuss the role played by DNA methylation, chromatin remodeling, noncoding RNAs and histone lactylation in tumor growth and progression. Finally, we summarize the prospects of potential cancer therapeutic strategies based on metabolic reprogramming and epigenetic changes in tumor cells.

摘要

代谢重编程和表观遗传修饰是癌细胞的标志。在癌细胞中,代谢途径的活性在肿瘤发生和癌症进展过程中发生变化,表明代谢具有调节的可塑性。代谢变化通常与表观遗传变化密切相关,例如表观遗传修饰酶的表达或活性的改变,这些改变可能对细胞代谢产生直接或间接的影响。因此,探索表观遗传修饰调节肿瘤细胞代谢重编程的机制对于进一步了解肿瘤发病机制非常重要。在这里,我们主要关注与癌症细胞代谢调控相关的表观遗传修饰的最新研究,包括在癌症背景下葡萄糖、脂质和氨基酸代谢的变化,然后强调与肿瘤细胞表观遗传修饰相关的机制。具体来说,我们讨论了 DNA 甲基化、染色质重塑、非编码 RNA 和组蛋白乳酸化在肿瘤生长和进展中的作用。最后,我们总结了基于肿瘤细胞代谢重编程和表观遗传变化的潜在癌症治疗策略的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/9101931ae610/12276_2023_1020_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/8eeadc447424/12276_2023_1020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/7d63d1c0f24e/12276_2023_1020_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/1726f9ca4dc7/12276_2023_1020_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/9101931ae610/12276_2023_1020_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/8eeadc447424/12276_2023_1020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/7d63d1c0f24e/12276_2023_1020_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/1726f9ca4dc7/12276_2023_1020_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da4/10394076/9101931ae610/12276_2023_1020_Fig4_HTML.jpg

相似文献

1
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.癌症中的代谢重编程和表观遗传修饰:从影响和机制到治疗潜力。
Exp Mol Med. 2023 Jul;55(7):1357-1370. doi: 10.1038/s12276-023-01020-1. Epub 2023 Jul 3.
2
Metabolic reprogramming and epigenetic modifications on the path to cancer.癌症发生过程中的代谢重编程和表观遗传修饰。
Protein Cell. 2022 Dec;13(12):877-919. doi: 10.1007/s13238-021-00846-7. Epub 2021 May 29.
3
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.分子途径:癌症中组蛋白甲基化和基因表达的代谢调控
Clin Cancer Res. 2017 Aug 1;23(15):4004-4009. doi: 10.1158/1078-0432.CCR-16-2506. Epub 2017 Apr 12.
4
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.代谢重编程与癌症表观遗传学的串扰:机制与治疗机会的更新。
Cancer Commun (Lond). 2022 Nov;42(11):1049-1082. doi: 10.1002/cac2.12374. Epub 2022 Oct 20.
5
Effect of non-enzymatic glycosylation in the epigenetics of cancer.非酶糖基化在癌症表观遗传学中的作用。
Semin Cancer Biol. 2022 Aug;83:543-555. doi: 10.1016/j.semcancer.2020.11.019. Epub 2020 Dec 2.
6
Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer.乳酸诱导的蛋白乳酰化:癌症中表观遗传学和代谢重编程之间的桥梁。
Cell Prolif. 2023 Oct;56(10):e13478. doi: 10.1111/cpr.13478. Epub 2023 Apr 14.
7
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
8
Rewriting cellular fate: epigenetic interventions in obesity and cellular programming.改写细胞命运:肥胖症和细胞编程中的表观遗传干预。
Mol Med. 2024 Oct 10;30(1):169. doi: 10.1186/s10020-024-00944-2.
9
The role of histone modifications in epigenetic transitions during normal and perturbed development.组蛋白修饰在正常和受干扰发育过程中的表观遗传转变中的作用。
Ernst Schering Res Found Workshop. 2006(57):1-27. doi: 10.1007/3-540-37633-x_1.
10
Epigenetic alterations in cancer.癌症中的表观遗传改变。
Front Biosci (Landmark Ed). 2020 Mar 1;25(6):1058-1109. doi: 10.2741/4847.

引用本文的文献

1
Effects of different exercise prescription parameters on metabolic and inflammatory biomarkers in cancer patients: a systematic review, meta-analysis, and meta-regression.不同运动处方参数对癌症患者代谢和炎症生物标志物的影响:一项系统评价、荟萃分析和荟萃回归
Front Immunol. 2025 Aug 14;16:1663560. doi: 10.3389/fimmu.2025.1663560. eCollection 2025.
2
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.NeuroD1驱动KAT2A-FDFT1信号轴,通过组蛋白H3K27乙酰化促进胆固醇生物合成和肝细胞癌进展。
Oncogene. 2025 Sep 1. doi: 10.1038/s41388-025-03534-6.
3

本文引用的文献

1
Structural insights into adhesion GPCR ADGRL3 activation and G, G, G, and G coupling.粘附GPCR ADGRL3激活以及与Gαs、Gαi、Gαq和Gα12偶联的结构见解。
Mol Cell. 2022 Nov 17;82(22):4340-4352.e6. doi: 10.1016/j.molcel.2022.10.009. Epub 2022 Oct 28.
2
The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition.FUS/circEZH2/KLF5 反馈环路通过增强上皮-间充质转化促进乳腺癌中 CXCR4 诱导的肝转移。
Mol Cancer. 2022 Oct 12;21(1):198. doi: 10.1186/s12943-022-01653-2.
3
Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticity.
转移性乳腺癌细胞通过DDX3-DRP1介导的线粒体可塑性对脂肪酸氧化抑制敏感。
Redox Biol. 2025 Aug 26;86:103845. doi: 10.1016/j.redox.2025.103845.
4
Targeting epigenetic modifications as an emerging immunotherapeutic strategy for cancers.将表观遗传修饰作为一种新兴的癌症免疫治疗策略。
Immunol Res. 2025 Aug 19;73(1):121. doi: 10.1007/s12026-025-09678-7.
5
Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies.铁死亡作为胶质母细胞瘤的治疗靶点:机制与新兴策略
Mol Ther Nucleic Acids. 2025 Jul 30;36(3):102649. doi: 10.1016/j.omtn.2025.102649. eCollection 2025 Sep 9.
6
DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment.DHCR24过表达参与脂质代谢重编程以驱动宫颈癌恶性进展,并与免疫微环境相关。
BMC Cancer. 2025 Aug 9;25(1):1291. doi: 10.1186/s12885-025-14663-2.
7
Melatonin: a natural guardian in cancer treatment.褪黑素:癌症治疗中的天然守护者。
Front Pharmacol. 2025 Jul 18;16:1617508. doi: 10.3389/fphar.2025.1617508. eCollection 2025.
8
Untargeted metabolomics analysis of serum metabolic signatures as novel biomarkers for gastric carcinoma.血清代谢特征的非靶向代谢组学分析作为胃癌的新型生物标志物
World J Clin Oncol. 2025 Jul 24;16(7):108967. doi: 10.5306/wjco.v16.i7.108967.
9
A novel defined manganese metabolism-related gene signature for predicting the prognosis of pancreatic ductal adenocarcinoma.一种用于预测胰腺导管腺癌预后的新型锰代谢相关基因特征。
Oncol Lett. 2025 Jul 9;30(3):436. doi: 10.3892/ol.2025.15182. eCollection 2025 Sep.
10
Long interspersed nuclear element 1 methylation in non-small cell lung cancer: implications for diagnosis, prognosis, and therapeutic targeting.非小细胞肺癌中长散在核元件1甲基化:对诊断、预后及治疗靶点的意义
Cell Commun Signal. 2025 Jul 22;23(1):350. doi: 10.1186/s12964-025-02343-4.
正电子发射断层扫描/计算机断层扫描在甲状腺癌中的应用。
PET Clin. 2022 Apr;17(2):265-283. doi: 10.1016/j.cpet.2021.12.004. Epub 2022 Mar 4.
4
MiR-601 Promotes Cell Proliferation of Human Glioblastoma Cells by Suppressing TINP1 Expression.miR-601 通过抑制 TINP1 表达促进人脑胶质瘤细胞的增殖。
Altern Ther Health Med. 2022 Feb;28(2):102-108.
5
Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism.DNA高甲基化导致的SLC27A6下调通过调节脂质代谢促进鼻咽癌增殖但抑制其转移。
Front Oncol. 2022 Jan 3;11:780410. doi: 10.3389/fonc.2021.780410. eCollection 2021.
6
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma.环状RPN2抑制肝细胞癌的有氧糖酵解和转移。
Cancer Res. 2022 Mar 15;82(6):1055-1069. doi: 10.1158/0008-5472.CAN-21-1259.
7
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer.miR-378a 通过抑制前列腺癌细胞中的 GLUT1 抑制葡萄糖代谢。
Oncogene. 2022 Mar;41(10):1445-1455. doi: 10.1038/s41388-022-02178-0. Epub 2022 Jan 17.
8
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
9
The cholesterol pathway: impact on immunity and cancer.胆固醇代谢途径:对免疫和癌症的影响。
Trends Immunol. 2022 Jan;43(1):78-92. doi: 10.1016/j.it.2021.11.007.
10
F FDG imaging - response criteria in tumors.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)成像-肿瘤的反应标准。
Eur J Radiol. 2022 Feb;147:110054. doi: 10.1016/j.ejrad.2021.110054. Epub 2021 Dec 3.